ES551659A0 - Procedimiento para preparar un reactivo para valorar por hemaglutinacion anticuerpos dirigidos contra toxinas bacterianas - Google Patents

Procedimiento para preparar un reactivo para valorar por hemaglutinacion anticuerpos dirigidos contra toxinas bacterianas

Info

Publication number
ES551659A0
ES551659A0 ES551659A ES551659A ES551659A0 ES 551659 A0 ES551659 A0 ES 551659A0 ES 551659 A ES551659 A ES 551659A ES 551659 A ES551659 A ES 551659A ES 551659 A0 ES551659 A0 ES 551659A0
Authority
ES
Spain
Prior art keywords
reagent
hemaglutination
assess
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES551659A
Other languages
English (en)
Other versions
ES8800757A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of ES551659A0 publication Critical patent/ES551659A0/es
Publication of ES8800757A1 publication Critical patent/ES8800757A1/es
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555Red blood cell
    • G01N33/556Fixed or stabilised red blood cell
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/967Standards, controls, materials, e.g. validation studies, buffer systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES551659A 1985-02-05 1986-02-05 Procedimiento para preparar un reactivo para valorar por hemaglutinacion anticuerpos dirigidos contra toxinas bacterianas Expired ES8800757A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8501579A FR2577048B1 (fr) 1985-02-05 1985-02-05 Reactif pour le dosage par hemagglutination des anticorps contre les toxines bacteriennes, procede de preparation et son application

Publications (2)

Publication Number Publication Date
ES551659A0 true ES551659A0 (es) 1987-11-16
ES8800757A1 ES8800757A1 (es) 1987-11-16

Family

ID=9315942

Family Applications (2)

Application Number Title Priority Date Filing Date
ES551659A Expired ES8800757A1 (es) 1985-02-05 1986-02-05 Procedimiento para preparar un reactivo para valorar por hemaglutinacion anticuerpos dirigidos contra toxinas bacterianas
ES557404A Expired ES8900068A1 (es) 1985-02-05 1987-02-16 Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557404A Expired ES8900068A1 (es) 1985-02-05 1987-02-16 Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas.

Country Status (11)

Country Link
US (1) US5318913A (es)
EP (1) EP0193439B1 (es)
JP (1) JPS61228356A (es)
AT (1) ATE68601T1 (es)
CA (1) CA1275043A (es)
DE (1) DE3681940D1 (es)
DK (1) DK56386A (es)
ES (2) ES8800757A1 (es)
FR (1) FR2577048B1 (es)
GR (1) GR860329B (es)
PT (1) PT81970B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6029998A (en) * 1997-01-17 1998-08-07 Regents Of The University Of Minnesota Dna molecules and protein displaying improved triazine compound degrading ability
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
DK1150918T3 (da) * 1999-02-03 2004-12-20 Biosante Pharmaceuticals Inc Fremgangsmåde til fremstilling af terapeutiske calciumphosphatpartikler
US20020068090A1 (en) * 1999-02-03 2002-06-06 Bell Steve J. D. Calcium phosphate particles as mucosal adjuvants
AU2001231155A1 (en) 2000-01-25 2001-08-07 Hugh Mctavish Microbes and methods for remediation
JP2002063917A (ja) * 2000-08-18 2002-02-28 Sony Corp 電気化学デバイス及びその使用方法
FR2821431B1 (fr) * 2001-02-28 2003-11-21 Louis Lery Reactif destine au depistage ante-morten d'atnc
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
WO2006050368A2 (en) 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles iin use for aesthetic or cosmetic medicine, and methods of manufacture and use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2310964A1 (de) * 1973-03-02 1974-09-05 Schering Ag Antigen- bzw. antigen-proteinkonjugatbeschichtete erythrocytenpraeparation
FR2334107A1 (fr) * 1975-12-05 1977-07-01 Pasteur Institut Procede de couplage de substances biologiques par des liaisons covalentes
FR2403559A1 (fr) * 1977-09-19 1979-04-13 Merieux Inst Nouveau reactif biologique, sa preparation et son application
DE2836046A1 (de) * 1978-08-17 1980-02-28 Behringwerke Ag Immunologisches bestimmungsverfahren
FR2478470A1 (fr) * 1980-03-24 1981-09-25 Pasteur Institut Preparations cellulaires applicables en therapeutique humaine, procede d'obtention et applications
JPS578090A (en) * 1980-06-12 1982-01-16 Shinsei Industries Co Stapler
US4403037A (en) * 1980-10-10 1983-09-06 American Hoechst Corporation Erythrocyte preparations and use thereof in hemagglutination tests
DE3206729A1 (de) * 1982-02-25 1983-09-01 Behringwerke Ag, 3550 Marburg Immunologisches agglutinationsverfahren
JPS5931453A (ja) * 1982-07-14 1984-02-20 Fujirebio Inc 梅毒抗体の測定方法

Also Published As

Publication number Publication date
ATE68601T1 (de) 1991-11-15
ES557404A0 (es) 1988-11-16
JPS61228356A (ja) 1986-10-11
EP0193439A1 (fr) 1986-09-03
FR2577048A1 (fr) 1986-08-08
ES8900068A1 (es) 1988-11-16
GR860329B (en) 1986-06-05
ES8800757A1 (es) 1987-11-16
DK56386D0 (da) 1986-02-05
CA1275043A (en) 1990-10-09
DE3681940D1 (de) 1991-11-21
DK56386A (da) 1986-08-06
FR2577048B1 (fr) 1988-05-06
PT81970B (pt) 1988-01-22
PT81970A (fr) 1986-03-01
EP0193439B1 (fr) 1991-10-16
US5318913A (en) 1994-06-07

Similar Documents

Publication Publication Date Title
ES8603271A1 (es) Un metodo de producir una composicion de interleuquina-2
EP0017708A3 (en) Immobilized glucose oxidase-catalase preparation and its use in the enzymatic oxidation of glucose
AU1141288A (en) Production of proteins in active forms
SE8602404D0 (sv) Ny formulering
ES2009143A6 (es) Procedimiento para acondicionamiento de una composicion anti-bacteriana
ES551659A0 (es) Procedimiento para preparar un reactivo para valorar por hemaglutinacion anticuerpos dirigidos contra toxinas bacterianas
FI874292A0 (fi) Foerfarande foer framstaellning av borsyrasuspensioner.
TW279890B (es)
ATE25806T1 (de) Halbfeuchtes haustierfutter mit freier sosse und verfahren zur herstellung desselben.
DK0401896T3 (da) Carboplatinmateriale
AU589970B2 (en) Animal litter and process for the production thereof
SE9002623D0 (sv) Vattenhaltig flytande enzymkomposition
DE3881386D1 (de) Bodenverbesserungsmittel.
NZ229632A (en) Fructosamine assay for body fluids
DE3673099D1 (de) Alkalivertraegliche amphoterische sulfobetain-tenside.
ES503537A0 (es) Procedimiento para la determinacion de hemoglobina.
ES8206973A1 (es) Procedimiento de preparar soluciones desagregadas de poli- peptidos
ES8306259A1 (es) "procedimiento para la preparacion de toxoplasmas coloreados".
IE822146L (en) Process and reagent for the determination of the activity of¹chymotrypsin or trypsin in faeces
DE3877988D1 (de) Verfahren zur bestimmung von protein c-inhibitor.
SU1445159A1 (ru) Способ поверхностного модифицирования резины
ATE26302T1 (de) Waessriges naehrmedium zur anzucht von mikroorganismen.

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506